| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 刘浩 | 华创证券 | 医药生物 | 74.31% | 76.53% | 17.18% | 20.00% | 2 | -47.33% | 2025-07-15 |
| 2 | 刘浩 | 华创证券 | 医药生物 | 74.31% | 72.54% | 32.63% | 20.00% | 2 | -47.33% | 2025-07-25 |
| 3 | 刘浩 | 华创证券 | 医药生物 | 73.38% | 67.64% | 49.54% | 20.00% | 2 | -47.33% | 2025-06-13 |
| 4 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 73.28% | 73.28% | 22.66% | 3.45% | 7 | -27.10% | 2025-07-01 |
| 5 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 73.13% | 60.54% | 38.36% | 3.45% | 6 | -27.10% | 2025-06-06 |
| 6 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 72.98% | 81.77% | 32.08% | 3.45% | 7 | -27.10% | 2025-07-10 |
| 7 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 72.86% | 65.50% | 50.11% | 3.45% | 6 | -27.10% | 2025-06-03 |
| 8 | 唐寅灏 | 中信证券 | 医药生物 | 72.85% | 76.73% | 40.11% | 60.00% | 13 | -8.47% | 2025-07-25 |
| 9 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 72.76% | 62.34% | 43.46% | 3.45% | 6 | -27.10% | 2025-06-05 |
| 10 | 刘浩 | 华创证券 | 医药生物 | 72.76% | 72.76% | 21.71% | 20.00% | 2 | -47.33% | 2025-07-01 |
| 11 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 72.66% | 79.33% | 41.53% | 3.45% | 7 | -27.10% | 2025-07-09 |
| 12 | 刘浩 | 华创证券 | 医药生物 | 72.64% | 73.02% | 16.85% | 20.00% | 2 | -47.33% | 2025-07-14 |
| 13 | 罗佳荣 | 广发证券 | 医药生物 | 72.45% | 26.46% | 6.90% | -2.63% | 12 | -76.45% | 2019-12-31 |
| 14 | 刘浩 | 华创证券 | 医药生物 | 72.04% | 59.80% | 41.45% | 20.00% | 2 | -47.33% | 2025-06-09 |
| 15 | 李安飞 | 广发证券 | 医药生物 | 71.06% | 58.17% | 47.02% | 2.86% | 1 | -56.96% | 2025-06-12 |
| 16 | 刘浩 | 华创证券 | 医药生物 | 70.98% | 64.74% | 42.31% | 20.00% | 2 | -47.33% | 2025-06-16 |
| 17 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 70.88% | 76.59% | 25.90% | 3.45% | 7 | -27.10% | 2025-07-04 |
| 18 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 70.68% | 76.38% | 25.75% | 3.45% | 7 | -27.10% | 2025-07-03 |
| 19 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 70.53% | 66.13% | 50.59% | 3.45% | 6 | -27.10% | 2025-05-30 |
| 20 | 阳景 | 浦银国际证券 | 医药生物 | 70.34% | 64.36% | 36.71% | 100.00% | 3 | 0.00% | 2025-07-29 |